Drug intelligence / Profile preview

Qinghua Bihui

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Qinghua Bihui is a traditional Chinese medicine (TCM) formulation developed and used in China, notably during the COVID-19 pandemic in Shanghai to help prevent and control the epidemic. It is administered as granules or decoctions. The formula consists of multiple TCM herbs, though the exact composition is not specified in available sources. Its mechanism of action is believed to involve immunomodulation and anti-inflammatory effects typical of TCM formulas used for respiratory infections. Clinical trials have been conducted to evaluate its efficacy and safety for mild COVID-19 cases[1][3]. The product has been produced at scale for public health interventions.

Brand names
Qinghua Bihui
Other names
Qinghua Bihui Granules
02

Targets

IL8 (C-X-C Motif Chemokine Ligand 8)IFNG (Interferon gamma)CCR5 (C-C chemokine receptor type 5)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)GM-CSF (Granulocyte-macrophage colony-stimulating factor)

Beyond the preview

Go deeper on Qinghua Bihui.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qinghua Bihui.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call